RecruitingMethamphetamine UseHeart Failure
Rural Community Peer Partnerships for Improving Methamphetamine-Associated Heart Failure Screening and Engagement
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The goal of PEER-Heart is to implement and assess feasibility and preliminary effectiveness of a community peer-facilitated screening for methamphetamine-associated heart failure (MAHF) and linkage to evidence-based cardiology care for people who use methamphetamine in rural areas.
Sponsor: Oregon Health and Science University
You may qualify if…
- ✓ Patient-defined regular use of methamphetamine in the last year
- ✓ Any methamphetamine use in the past 30 days
- ✓ Age 18 years or older
- ✓ No client-reported diagnosis of heart failure
- ✓ Able to communicate in English
- ✓ Screen positive for potential methamphetamine-associated heart failure (MAHF) defined as B type natriuretic peptide (BNP) ≥50 pg/ml, or QRS width ≥120ms, or presence of any clinical heart failure symptoms
You may not qualify if…
- ✕ Self-reported engagement in medical care for heart failure in past 6 months.
- ✕ Actively taking medications for heart failure.
Where it's recruiting
Oregon
Portland
Source: ClinicalTrials.gov · NCT06461962 · last updated 2025-03-21